$14.31
4.54% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US83601L1026
Symbol
SHC

Sotera Health Co Target price 2024 - Analyst rating & recommendation

Sotera Health Co Classifications & Recommendation:

Buy
63%
Hold
38%

Sotera Health Co Price Target

Target Price $17.43
Price $14.31
Potential
Number of Estimates 7
7 Analysts have issued a price target Sotera Health Co 2025 . The average Sotera Health Co target price is $17.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 5 Analysts recommend Sotera Health Co to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2025 of . Most analysts recommend the Sotera Health Co stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 1.05 1.10
4.54% 5.18%
EBITDA Margin 49.25% 50.06%
3.58% 1.64%
Net Margin 4.86% 9.05%
120.74% 86.26%

7 Analysts have issued a sales forecast Sotera Health Co 2024 . The average Sotera Health Co sales estimate is

$1.1b
Unlock
. This is
1.51% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.1b 1.21%
Unlock
, the lowest is
$1.1b 1.93%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $1.0b 4.54%
2024
$1.1b 5.18%
Unlock
2025
$1.2b 5.99%
Unlock
2026
$1.3b 6.90%
Unlock

7 Analysts have issued an Sotera Health Co EBITDA forecast 2024. The average Sotera Health Co EBITDA estimate is

$552m
Unlock
. This is
4.89% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$557m 5.75%
Unlock
, the lowest is
$550m 4.41%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $517m 8.29%
2024
$552m 6.89%
Unlock
2025
$594m 7.45%
Unlock
2026
$641m 7.96%
Unlock

EBITDA Margin

2023 49.25% 3.58%
2024
50.06% 1.64%
Unlock
2025
50.75% 1.38%
Unlock
2026
51.25% 0.99%
Unlock

4 Sotera Health Co Analysts have issued a net profit forecast 2024. The average Sotera Health Co net profit estimate is

$99.8m
Unlock
. This is
41.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$198m 180.00%
Unlock
, the lowest is
$62.3m 12.00%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $51.0m 121.69%
2024
$99.8m 95.83%
Unlock
2025
$163m 63.12%
Unlock
2026
$200m 22.61%
Unlock

Net Margin

2023 4.86% 120.74%
2024
9.05% 86.26%
Unlock
2025
13.92% 53.81%
Unlock
2026
15.97% 14.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.18 0.35
121.69% 94.44%
P/E 40.60
EV/Sales 5.53

4 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.35
Unlock
. This is
40.00% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.70 180.00%
Unlock
, the lowest is
$0.22 12.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $0.18 121.69%
2024
$0.35 94.44%
Unlock
2025
$0.58 65.71%
Unlock
2026
$0.71 22.41%
Unlock

P/E ratio

Current 57.66 586.58%
2024
40.60 29.59%
Unlock
2025
24.89 38.69%
Unlock
2026
20.30 18.44%
Unlock

Based on analysts' sales estimates for 2024, the Sotera Health Co stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.45 5.87%
2024
5.53 1.46%
Unlock
2025
5.22 5.65%
Unlock
2026
4.88 6.45%
Unlock

P/S ratio

Current 3.62 2.09%
2024
3.67 1.53%
Unlock
2025
3.47 5.65%
Unlock
2026
3.24 6.45%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today